# Intraoperative Radiotherapy for Korean Patients With Breast Cancer

Source: https://onco.cc/trials/nct02213991/  
OnCo record `nct02213991` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Intraoperative radiotherapy in Breast cancer, run by Gangnam Severance Hospital, with a status the registry has not verified recently.

## Summary

Intraoperative Radiotherapy for Korean Patients With Breast Cancer is a phase 2 interventional study registered as NCT02213991 by Gangnam Severance Hospital, with 215 participants planned, started 2014-08 and due to reach its primary completion in 2017-10. Interventions recorded: Intraoperative radiotherapy using Intrabeam®. Conditions recorded: Breast Cancer.

Linked to the technology Intraoperative radiotherapy because the registry names it ("intraoperative radiotherapy") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT02213991
- Phase: 2
- Setting: A Phase II Trial Investigating Acute Local Toxicities of Intraoperative Radiotherapy as a Boost Dose in Korean Breast Cancer Patients Undergoing Breast Conserving Surgery
- Sponsor: Gangnam Severance Hospital
- Enrolled: 215

## Sources

- ClinicalTrials.gov NCT02213991: https://clinicaltrials.gov/study/NCT02213991

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- technologies: [Intraoperative radiotherapy (IORT)](https://onco.cc/technologies/intraoperative-radiotherapy/)

---
JSON: https://onco.cc/api/v1/entities/nct02213991.json